BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 31027734)

  • 1. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.
    Liu H; Zheng H; Duan Z; Hu D; Li M; Liu S; Li Z; Deng X; Wang Z; Tang M; Shi Y; Yi W; Cao Y
    Mol Cancer; 2009 Oct; 8():92. PubMed ID: 19860880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id1 interacts and stabilizes the Epstein-Barr virus latent membrane protein 1 (LMP1) in nasopharyngeal epithelial cells.
    Hau PM; Tsang CM; Yip YL; Huen MS; Tsao SW
    PLoS One; 2011; 6(6):e21176. PubMed ID: 21701587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LMP1 Induces p53 Protein Expression via the H19/miR-675-5p Axis.
    Li J; Zhang Y; Sun L; Liu S; Zhao M; Luo B
    Microbiol Spectr; 2022 Jun; 10(3):e0000622. PubMed ID: 35674441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9.
    Lan YY; Hsiao JR; Chang KC; Chang JS; Chen CW; Lai HC; Wu SY; Yeh TH; Chang FH; Lin WH; Su IJ; Chang Y
    J Virol; 2012 Jun; 86(12):6656-67. PubMed ID: 22514348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy.
    Lechner M; Schartinger VH; Steele CD; Nei WL; Ooft ML; Schreiber LM; Pipinikas CP; Chung GT; Chan YY; Wu F; To KF; Tsang CM; Pearce W; Morelli D; Philpott M; Masterson L; Nibhani R; Wells G; Bell CG; Koller J; Delecluse S; Yip YL; Liu J; Forde CT; Forster MD; Jay A; Dudás J; Krapp A; Wan S; Uprimny C; Sprung S; Haybaeck J; Fenton TR; Chester K; Thirlwell C; Royle G; Marafioti T; Gupta R; Indrasari SR; Herdini C; Slim MAM; Indrawati I; Sutton L; Fles R; Tan B; Yeong J; Jain A; Han S; Wang H; Loke KSH; He W; Xu R; Jin H; Cheng Z; Howard D; Hwang PH; Le QT; Tay JK; West RB; Tsao SW; Meyer T; Riechelmann H; Oppermann U; Delecluse HJ; Willems SM; Chua MLK; Busson P; Lo KW; Wollmann G; Pillay N; Vanhaesebroeck B; Lund VJ
    Nat Commun; 2021 Jan; 12(1):117. PubMed ID: 33402692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anoikis resistance and immune escape mediated by Epstein-Barr virus-encoded latent membrane protein 1-induced stabilization of PGC-1α promotes invasion and metastasis of nasopharyngeal carcinoma.
    Liao C; Li M; Chen X; Tang C; Quan J; Bode AM; Cao Y; Luo X
    J Exp Clin Cancer Res; 2023 Oct; 42(1):261. PubMed ID: 37803433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells.
    Lai XF; Shen CX; Wen Z; Qian YH; Yu CS; Wang JQ; Zhong PN; Wang HL
    J Exp Clin Cancer Res; 2012 Feb; 31(1):12. PubMed ID: 22316341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
    Van Sciver N; Ohashi M; Nawandar DM; Pauly NP; Lee D; Makielski KR; Bristol JA; Tsao SW; Lambert PF; Johannsen EC; Kenney SC
    PLoS Pathog; 2021 Nov; 17(11):e1010045. PubMed ID: 34748616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus LMP1 manipulates the content and functions of extracellular vesicles to enhance metastatic potential of recipient cells.
    Nkosi D; Sun L; Duke LC; Meckes DG
    PLoS Pathog; 2020 Dec; 16(12):e1009023. PubMed ID: 33382850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma.
    Liao Y; Zhang JB; Lu LX; Jia YJ; Zheng MQ; Debelius JW; He YQ; Wang TM; Deng CM; Tong XT; Xue WQ; Cao LJ; Wu ZY; Yang DW; Zheng XH; Li XZ; Wu YX; Feng L; Ye W; Mu J; Jia WH
    Microbiol Spectr; 2023 Feb; 11(1):e0344822. PubMed ID: 36645283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes.
    Singh DR; Nelson SE; Pawelski AS; Cantres-Velez JA; Kansra AS; Pauly NP; Bristol JA; Hayes M; Ohashi M; Casco A; Lee D; Fogarty SA; Lambert PF; Johannsen EC; Kenney SC
    PLoS Pathog; 2022 Oct; 18(10):e1010868. PubMed ID: 36190982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ubiquitin Sensor and Adaptor Protein p62 Mediates Signal Transduction of a Viral Oncogenic Pathway.
    Wang L; Howell MEA; Sparks-Wallace A; Zhao J; Hensley CR; Nicksic CA; Horne SR; Mohr KB; Moorman JP; Yao ZQ; Ning S
    mBio; 2021 Oct; 12(5):e0109721. PubMed ID: 34488443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of LMP1 in Epstein-Barr Virus-associated Gastric Cancer.
    Huang X; Zhang M; Zhang Z
    Curr Cancer Drug Targets; 2024; 24(2):127-141. PubMed ID: 37183458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma.
    Mizokami H; Okabe A; Choudhary R; Mima M; Saeda K; Fukuyo M; Rahmutulla B; Seki M; Goh BC; Kondo S; Dochi H; Moriyama-Kita M; Misawa K; Hanazawa T; Tan P; Yoshizaki T; Fullwood MJ; Kaneda A
    EBioMedicine; 2024 Apr; 102():105057. PubMed ID: 38490101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ.
    Singh DR; Nelson SE; Pawelski AS; Kansra AS; Fogarty SA; Bristol JA; Ohashi M; Johannsen EC; Kenney SC
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2219755120. PubMed ID: 37155846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post cross-linked ROS-responsive poly(β-amino ester)-plasmid polyplex NPs for gene therapy of EBV-associated nasopharyngeal carcinoma.
    Yuan C; Chang S; Zhang C; Dong D; Ding J; Mahdavian AR; Hu Z; Sun L; Tan S
    J Mater Chem B; 2024 Mar; 12(12):3129-3143. PubMed ID: 38451208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
    Chen H; Lee JM; Zong Y; Borowitz M; Ng MH; Ambinder RF; Hayward SD
    J Virol; 2001 Mar; 75(6):2929-37. PubMed ID: 11222718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells.
    Wu CC; Chen MS; Lee TY; Huang TS; Cho DY; Chen JY
    Viral Immunol; 2024 Mar; 37(2):115-123. PubMed ID: 38498796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EBV LMP1-C terminal binding affibody molecule downregulates MEK/ERK/p90RSK pathway and inhibits the proliferation of nasopharyngeal carcinoma cells in mouse tumor xenograft models.
    Guo Y; Kamara S; Zhang J; Wen H; Zheng M; Liu Y; Zhou L; Chen J; Zhu S; Zhang L
    Front Cell Infect Microbiol; 2022; 12():1078504. PubMed ID: 36683690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.